Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin

Lancet. 1994 Aug 27;344(8922):581-2. doi: 10.1016/s0140-6736(94)91967-4.

Abstract

Biliary stents are liable to clog. We investigated whether a choleretic plus an antibiotic could delay clogging. 20 consecutive patients with a malignant biliary stricture were randomised after endoscopic insertion of a polyethylene stent to receive ursodeoxycholic acid plus norfloxacin (13-15 mg/kg and 400 mg, daily) or conservative treatment. The drug combination was associated with: a longer median patency of first (49 vs 6 weeks) and all stents (38 vs 7 weeks); a prolonged median survival (67 vs 18 weeks); and a shorter mean hospital stay (0.2 vs 1.0 days per week of survival). Thus ursodeoxycholic acid plus norfloxacin may prevent stent clogging.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Bile Ducts*
  • Cholestasis / etiology
  • Cholestasis / surgery
  • Constriction, Pathologic
  • Drug Therapy, Combination
  • Humans
  • Norfloxacin / administration & dosage*
  • Norfloxacin / therapeutic use
  • Stents* / adverse effects
  • Ursodeoxycholic Acid / administration & dosage*
  • Ursodeoxycholic Acid / therapeutic use

Substances

  • Ursodeoxycholic Acid
  • Norfloxacin